BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30616591)

  • 1. Critically appraised topic for the most effective and safe treatment for canine generalised demodicosis.
    Perego R; Spada E; Foppa C; Proverbio D
    BMC Vet Res; 2019 Jan; 15(1):17. PubMed ID: 30616591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A European field assessment of the efficacy of fluralaner (Bravecto
    Petersen I; Chiummo R; Zschiesche E; Karas-Tecza J; Rapti D; Roepke R; Thomas E
    Parasit Vectors; 2020 Jun; 13(1):304. PubMed ID: 32527282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of topically administered fluralaner or imidacloprid/moxidectin on dogs with generalised demodicosis.
    Fourie JJ; Meyer L; Thomas E
    Parasit Vectors; 2019 Jan; 12(1):59. PubMed ID: 30683143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of oral fluralaner for the treatment of canine generalized demodicosis: a molecular-level confirmation.
    Djuric M; Milcic Matic N; Davitkov D; Glavinic U; Davitkov D; Vejnovic B; Stanimirovic Z
    Parasit Vectors; 2019 May; 12(1):270. PubMed ID: 31138280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes.
    Paterson TE; Halliwell RE; Fields PJ; Louw ML; Ball G; Louw J; Pinckney R
    Vet Parasitol; 2014 Oct; 205(3-4):687-96. PubMed ID: 25262617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis.
    Beugnet F; Halos L; Larsen D; de Vos C
    Parasite; 2016; 23():14. PubMed ID: 27012161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe.
    Lebon W; Beccati M; Bourdeau P; Brement T; Bruet V; Cekiera A; Crosaz O; Darmon C; Guillot J; Mosca M; Pin D; Popiel J; Pomorska Handwerker D; Larsen D; Tielemans E; Beugnet F; Halos L
    Parasit Vectors; 2018 Sep; 11(1):506. PubMed ID: 30201031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.
    Fourie JJ; Liebenberg JE; Horak IG; Taenzler J; Heckeroth AR; Frénais R
    Parasit Vectors; 2015 Mar; 8():187. PubMed ID: 25881320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluralaner 5.46% (w/w) flavored chewable tablet (Bravecto
    Rohdich N; Meyer L; Guerino F
    Parasit Vectors; 2022 Mar; 15(1):83. PubMed ID: 35279216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on the therapy of canine demodicosis.
    Mueller RS
    Compend Contin Educ Vet; 2012 Apr; 34(4):E1-4. PubMed ID: 22488596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The main factors influencing canine demodicosis treatment outcome and determination of optimal therapy.
    Arsenović M; Pezo L; Vasić N; Ćirić R; Stefanović M
    Parasitol Res; 2015 Jul; 114(7):2415-26. PubMed ID: 26013574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectes cynotis.
    Six RH; Becskei C; Mazaleski MM; Fourie JJ; Mahabir SP; Myers MR; Slootmans N
    Vet Parasitol; 2016 May; 222():62-6. PubMed ID: 26971196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of sarolaner against generalized demodicosis in dogs in European countries: a non-inferiority study.
    Becskei C; Cuppens O; Mahabir SP
    Vet Dermatol; 2018 Jun; 29(3):203-e72. PubMed ID: 29423956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of lotilaner (Credelio™), a novel oral isoxazoline against naturally occurring mange mite infestations in dogs caused by Demodex spp.
    Snyder DE; Wiseman S; Liebenberg JE
    Parasit Vectors; 2017 Nov; 10(1):532. PubMed ID: 29089049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of refractory demodicosis and transient papules with a single dose of fluralaner in a dog with uncontrolled severe endocrine disease.
    Morita T; Momota Y; Mori A; Oda H; Ike K; Sako T
    J Vet Med Sci; 2018 Apr; 80(4):672-675. PubMed ID: 29515061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of canine generalized demodicosis using weekly injections of doramectin: 232 cases in the USA (2002-2012).
    Hutt JH; Prior IC; Shipstone MA
    Vet Dermatol; 2015 Oct; 26(5):345-9, e73. PubMed ID: 26190685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of demodicosis in dogs: 2011 clinical practice guidelines.
    Mueller RS; Bensignor E; Ferrer L; Holm B; Lemarie S; Paradis M; Shipstone MA
    Vet Dermatol; 2012 Apr; 23(2):86-96, e20-1. PubMed ID: 22329600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A field trial in Thailand of the efficacy of oral fluralaner for the treatment of dogs with generalized demodicosis.
    Duangkaew L; Larsuprom L; Anukkul P; Lekcharoensuk C; Chen C
    Vet Dermatol; 2018 Jun; 29(3):208-e74. PubMed ID: 29424108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of sarolaner in the treatment of canine ear mite infestation caused by Otodectes cynotis: a non-inferiority study.
    Becskei C; Cuppens O; Mahabir SP
    Vet Dermatol; 2018 Apr; 29(2):100-e39. PubMed ID: 29392787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a combination of selamectin plus sarolaner for the treatment and prevention of flea infestations and the treatment of ear mites in cats presented as veterinary patients in the United States.
    Vatta AF; Myers MR; Rugg JJ; Chapin S; Pullins A; King VL; Rugg D
    Vet Parasitol; 2019 Jun; 270 Suppl 1():S3-S11. PubMed ID: 30579753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.